Key facts
- This page summarizes Genexine Inc.'s Form 4 filing for Rezolute, Inc. (RZLT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Jul 2021, 17:24.
Genexine Inc. - 26 Apr 2019 Form 4 Insider Report for Rezolute, Inc. (RZLT)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- RZLT
- Reported as of
- 26 Apr 2019
- Net transaction value
- -$2,500,000
- SEC form
- 4
- Accepted by SEC
- 28 Jul 2021, 17:24:44 UTC
- Prior SEC filing
- 28 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Genexine, Inc., by Sung June Hong, CFO
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Genexine Inc. filed Form 4 for Rezolute, Inc. (RZLT) on 28 Jul 2021.
Change
- Previous filing in this sequence was filed on 28 Jul 2021.
- Current net transaction value: -$2,500,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RZLT
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +56,818,175
- Change %
- Price
- Shares after
- 56,818,175
- Date
- 26 Apr 2019
- Ownership
- Direct
- Footnotes
- F1, F2
RZLT
transaction
Common Stock
Purchase
- Transaction value
- $10,000,000
- Shares
- +34,482,758
- Change %
- +61%
- Price
- $0.2900*
- Shares after
- 91,300,933
- Date
- 23 Jul 2019
- Ownership
- Direct
- Footnotes
- F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RZLT
transaction
Derivative
Series AA Preferred Stock
Conversion of derivative security
- Transaction value
- $12,500,000
- Shares
- -1,250,000
- Change %
- -100%
- Price
- $10.00*
- Shares after
- 0
- Date
- 26 Apr 2019
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 56,818,175
- Exercise price
- $0.2200
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Reporting Person acquired 1,250,000 shares of Issuer's Series AA Preferred Stock on January 30, 2019. Each share of the Issuer's Series AA Preferred Stock is convertible into shares of the Issuer's Common Stock at a ratio of 45.45454 shares of Common Stock for one share of Series AA Preferred Stock ("Conversion Rate") at the holder's election and has no expiration date. The Series AA Preferred Stock will automatically convert, at the Conversion Rate, into Common Stock (i) at any time upon the vote or consent of the holders of two thirds of the voting power of the then outstanding Series AA Preferred Stock or (ii) the amendment to Issuer's Certificate of Incorporation to increase the number of shares of Common Stock authorized to be issued to at least 500,000,000 shares of Common Stock.
Footnote F2
Upon the filing of Issuer's amendment to Certificate of Incorporation on April 26, 2019, which amendment increased the authorized number of shares of Common Stock of the Issuer to 500,000,000, each share of Series AA Preferred Stock automatically converted into shares of the Issuer's Common Stock at the Conversion Rate.
Footnote F3
Issuer granted Reporting Person a call option whereby the earlier of, (i) December 31, 2020 and (ii) the date when Issuer asks Reporting Person for further financing, Reporting Person may elect to purchase up to $10,000,000 worth of shares of the Issuer's Common Stock at a purchase price equal to the greater of: (i) $0.29 per share or (ii) 75% of the volume weighted average closing price of the Issuer's Common Stock during the thirty (30) consecutive trading days prior to the date of the notice. Pursuant to a Purchase Agreement for Shares of Common Stock dated July 23, 2019, Reporting Person exercised the full call option to purchase Common Stock.
Footnote F4
Such amount now represents 1,826,019 shares of common stock after taking into account the 50:1 reverse stock split effected October 7, 2020.